Internal Medicine, Pulmonary Disease · Los Angeles, CA
NPI
1174814701
Since 2011
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
10833 Le Conte Ave, UCLA Center for Health Sciences 37-131, Box 951690
Los Angeles, CA, 90095
Phone (310) 825-8599
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
1,029 services
Medicare patients, 2024
168
Average age 66
Drug cost, 2024
$1.9M
1,947 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ariss Derhovanessian was code 99291 (critical care e&m), 224 times for 46 patients. In total Ariss Derhovanessian billed 1,029 services in 22 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 224 | 46 | $172.57 | $39K |
| 99233 Hospital E&M - Subsequent | Facility | 186 | 46 | $94.37 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 168 | 68 | $13.58 | $2,281 |
| 99215 Office E&M - Established | Facility | 138 | 35 | $115.10 | $16K |
| 99214 Office E&M - Established | Facility | 94 | 53 | $69.90 | $6,571 |
| 99232 Hospital E&M - Subsequent | Facility | 64 | 34 | $65.03 | $4,162 |
| 99223 Hospital E&M - Initial | Facility | 29 | 26 | $136.41 | $3,956 |
| 31624 Bronchoscopy | Facility | 20 | 16 | $108.79 | $2,176 |
| 99213 Office E&M - Established | Facility | 16 | 14 | $48.49 | $776 |
By year: 2022 $104K for 967 services; 2023 $95K for 831 services; 2024 $99K for 1,029 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ariss Derhovanessian prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 198 prescriptions and refills. In total Ariss Derhovanessian wrote 1,947 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 198 | 417 | 48 | $1,124 |
| Prednisone Generic | 181 | 341 | 47 | $966 |
| Pantoprazole Sodium Generic | 128 | 284 | 33 | $1,542 |
| Azithromycin Generic | 127 | 265 | 36 | $1,809 |
| Tacrolimus Generic | 118 | 190 | 23 | $15K |
| Pravastatin Sodium Generic | 81 | 172 | 19 | $923 |
| Valganciclovir Hcl Generic | 76 | 106 | 22 | $17K |
| Mycophenolate Mofetil Generic | 61 | 117 | 15 | $6,730 |
| Alendronate Sodium Generic | 58 | 143 | 23 | $523 |
| Prevymis Letermovir | 57 | 57 | Under 11 | $396K |
| Ofev Nintedanib Esylate | 56 | 56 | Under 11 | $730K |
| Metoprolol Tartrate Generic | 55 | 136 | 17 | $463 |
| Acyclovir Generic | 51 | 110 | 12 | $1,073 |
| Posaconazole Generic | 47 | 47 | 11 | $30K |
| Eliquis Apixaban | 36 | 57 | Under 11 | $32K |
Brand drugs: 293 claims; generic drugs: 1,654 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ariss Derhovanessian were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.